FDA Approves AbbVie's Rinvoq As Once-Daily Pill For Crohn's Disease In Adults
19/5 05:06
(RTTNews) - The U.S. Food and Drug Administration approved AbbVie's (ABBV) Rinvoq or upadacitinib for the treatment of adults with moderately to severely active Crohn's disease who have had an inadequate response or intolerance to one or more TNF blockers....